Press Releases GenSight Biologics S.A.

Equities

SIGHT

FR0013183985

Market Closed - Euronext Paris Other stock markets 11:35:19 2024-04-30 am EDT			5-day change	1st Jan Change
0.395 ^EUR	-3.66%		-3.54%	-14.13%

Apr. 05	GenSight: financial visibility assured until the end of April	CF
Mar. 25	GenSight: share price falls, limited financial visibility	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GenSight Biologics S A : Inside Information / News release on accounts, results	Apr. 18	PU
GenSight Biologics Announces the Filing of its 2023 Universal Registration Document	Apr. 18	BU
GenSight Biologics S A : Announces the Filing of its 2023 Universal Registration Document	Apr. 17	PU
GenSight Biologics Reports Cash Position as of March 31, 2024, and Provides Business Update	Apr. 04	BU
GenSight Biologics Announces its 2024 Financial Calendar	Apr. 04	BU
GenSight Biologics S A : Reports Cash Position as of March 31, 2024, and Provides Business Update	Apr. 04	PU
GenSight Biologics S A : Announces Its 2024 Financial Calendar	Apr. 04	PU
GenSight Biologics Reports Full Year 2023 Consolidated Financial Results	Mar. 22	BU
GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections Four Years After One-Time Administration	Mar. 20	BU
GenSight Biologics Announces Initial Results from New Meta-Analyses on Visual Outcomes with LUMEVOQ Gene Therapy at NANOS 2024	Mar. 13	AQ
GenSight Biologics Announces Initial Results from New Meta-Analyses on Visual Outcomes with LUMEVOQ® Gene Therapy at NANOS 2024	Mar. 12	BU
GenSight Biologics Announces Update on Real-World Data from Early Access Programs of LUMEVOQ Gene Therapy at NANOS 2024	Mar. 07	AQ
GenSight Biologics Announces Update on Real-World Data from Early Access Programs of LUMEVOQ® Gene Therapy at NANOS 2024	Mar. 06	BU
GenSight Biologics S A : Inside Information / Other news releases	Mar. 04	PU
GenSight Biologics S A : Inside Information / Other news releases	Dec. 22	PU
GenSight Biologics S A : Notice of Extraordinary General Meeting – EGM January 10, 2024	Dec. 21	PU
GenSight Biologics S A : Reports Cash Position as of September 30, 2023, and Provides Business Update	23-10-26	PU
GenSight Biologics S A : CORPORATE PRESENTATION – OCTOBER 2023	23-10-04	PU
GenSight Biologics S A : 2023 HALF-YEAR FINANCIAL REPORT	23-09-18	PU
GenSight Biologics S A : CORPORATE PRESENTATION-SEPTEMBER 2023	23-09-11	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases GenSight Biologics S.A.

Equities

SIGHT

FR0013183985

Press Releases

Filters